Can GLP-1s Like Ozempic Reverse Type 2 Diabetes?

Despite these remarkable effects, experts generally don’t consider this success equivalent to diabetes reversal or remission, because GLP-1 drugs typically require ongoing use to keep type 2 diabetes under control.

Health experts don’t use the word “reversal” for type 2 diabetes. They tend to prefer “remission,” which better acknowledges the lasting nature of the condition rather than suggesting it’s something that can be cured.

“Type 2 diabetes is a chronic metabolic disease, even when blood sugar improves significantly,” says Randa Abdelmasih, MD, an assistant professor of medicine in the division of endocrinology and metabolism at the University of Texas Medical Branch in Galveston.

“Many patients can achieve normal or near-normal glucose levels, but the underlying drivers — particularly insulin resistance and excess adiposity [body fat] — often persist,” says Dr. Abdelmasih.

“Type 2 diabetes should be treated as an ongoing condition that can become inactive, but may return,” says Betul Hatipoglu, MD, the director of Case Western Reserve University’s Diabetes, Obesity, and Metabolism Center in Cleveland.

GLP-1 drugs were approved for the treatment of diabetes on the strength of large studies showing that they significantly lowered blood sugar levels.

“What’s important from a metabolic standpoint is that improvements are closely tied to meaningful weight loss and improved insulin resistance, reinforcing that we are increasingly treating type 2 diabetes as part of a broader chronic metabolic disease driven by excess adiposity [body fat],” says Abdelmasih.

Though GLP-1 drugs are potent enough to help many people with diabetes achieve blood sugar levels below the diabetic range, this kind of success isn’t technically considered diabetes remission. GLP-1 medications generally work only while they’re being taken, and if you need medication to keep your blood sugar on target, you’re still considered to have full-blown type 2 diabetes.

“That’s exactly why the definition of remission excludes ongoing drug therapy,” says Dr. Hatipoglu. “If someone needs semaglutide or tirzepatide to keep [their] glucose normal, the medication is functioning as chronic treatment. It’s much like an antihypertensive keeping blood pressure controlled, or statins for cholesterol.”

People with type 2 diabetes can still enjoy very good outcomes with GLP-1 use, but the improvement is better described as well-controlled diabetes or prediabetes on therapy rather than remission, says Hatipoglu.

• GLP-1 medications like semaglutide and tirzepatide are highly effective at lowering A1C levels and body weight, often bringing participants’ blood sugar levels into a normal range during clinical trials.
• Medical experts define type 2 diabetes remission as maintaining an A1C below 6.5 percent for at least three months without the use of any glucose-lowering medications.
• Because GLP-1 drugs don’t eliminate the root causes of type 2 diabetes and typically require ongoing use to maintain results, they’re considered a chronic treatment rather than a method of reversing the disease.
• When patients stop taking these medications, they often experience significant weight regain and the return of higher blood sugar levels, reinforcing the need for long-term management.